Smith & Nephew

Smith & Nephew Overview

Company Headquarter: London, UK

Founded: 1856

Workforce: 15000 employees

Company Working: Smith & Nephew develops and markets medical devices worldwide. The company operates through four segments, namely, sports medicine, trauma, orthopedic reconstruction, and advanced wound management. The company primarily serves the providers of medical and surgical treatments and services. In 2014, Smith & Nephew acquired ArthroCare to broaden its sports medicine segment. The company has also acquired Healthpoint Biotherapeutics, which specializes in the production of bioactive for advanced wound management. Smith & Nephew has its presence in more than 100 countries and has major manufacturing units in the US, the UK, Switzerland, Germany, and China.

Strategy

Smith & Nephew strategizes to research, develop, manufacture, and market products which are technologically advanced and innovative. It also focuses on winning in established markets, accelerating development in emerging markets, innovating for value, simplifying and improving the operating model, and supplementing organic growth through acquisitions.

Company Snapshot

$4,669M

Revenue

15,000

Employees

1856

Founded

SWOT Analysis

Strengths

Leadership in advanced wound management
Consistency in sales which maintains the financial position
Worldwide operations
Strong brand equity
Stable cash flow
Large customer base
Strong product portfolio
The company has a strong global manufacturing facility
Focused on R&D programmes and investments in product and technology acquisitions
To drive innovation, Smith & Nephew invested around 5% of its revenue in R&D
Presence in key markets

Weaknesses

Low market capitalization compared to competitors
Controversies regarding allegations of corruption against the US and German subsidiaries
Risk management process
Unstable internal matters
The company has low to moderate tolerance towards managing suppliers and facilities
Low to moderate tolerance for cyber security risk
Instable internal matters

Opportunities

Growth through acquisitions
Create sustainable business in emerging markets
Entering emerging countries
Broadening product portfolio
Supplement organic growth with acquisitions
Improving execution to accelerate organic performance
Transforming the business through enabling technologies such as robotics, imaging, and augmented reality
Entering the emerging countries

Threats

Changing competitive landscape
Fluctuating economies
New government regulations
Insufficient long-term planning
Low value business segment investment such as product maintenance and line extension projects
Global political uncertainty regarding trade policy
New government regulation

Key Developments

Date	Approach	Development
December 2019	Acquisition	Smith & Nephew PLC acquired Osiris Therapeutics, Inc., a US-based company researching, developing, and marketing regenerative medicine products. The acquisition was aimed to accelerate growth from Smith & Nephew’s Advanced Wound Management franchise.
June 2019	Product Launch	Smith & Nephew launched PICO 14 single-use negative pressure wound therapy system and presented new evidence to help improve outcomes in hard to heal wounds. The product was introduced at the European Wound Management Association conference, Gothenburg, Sweden.
October 2017	Product Launch	Smith & Nephew announced the European launch of handheld imaging technology, heralding a new era of evidence-based decision making in wound care. It can measure the wound surface area and visualizes the presence and distribution of potentially harmful bacteria in wounds.
July 2017	Collaboration	Smith & Nephew and the University of Hull entered into a long-term collaboration for research on advanced wound care. The partnership creates one of the world’s largest Wound Care Research Clusters, combining world-leading academia and industry to develop scientific insights and innovative treatments for advanced wound care.
March 2019	Product Launch	Smith & Nephew launched a multi-asset digital surgery and robotic ecosystem. This platform reduces physical footprint, which makes it an ideal solution for surgical settings, including ambulatory surgical centers.
December 2017	Product Launch	Smith & Nephew launched the first robotics-assisted bicruciate retaining total knee replacement procedures.
June 2017	Product Launch	Smith & Nephew launched its NAVIO handheld robotics-assisted total knee arthroplasty (TKA) application. With this, it expanded the NAVIO platform to total knees, which comprises 80% of all knee replacement surgeries globally.

Product Offering

Smith & Nephew
- Orthopedic Reconstruction
- Robotics Assistance
- Wound Management

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.